A phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) in combination with pazopanib in patients with advanced soft tissue sarcoma (STS)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Attia, S; Riedel, RF; Robinson, SI; Conry, RM; Sankhala, KK; Seon, BK; Alvarez, D; Adams, BJ; Theuer, CP; Maki, RG

Published Date

  • May 20, 2015

Published In

Volume / Issue

  • 33 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Conference Location

  • Chicago, IL

Conference Start Date

  • May 29, 2015

Conference End Date

  • June 2, 2015